News (114)

Spain's Tendam wants to launch IPO before February 2025, CEO says RE
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update GL
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update GL
Transcript : ALX Oncology Holdings Inc. Presents at UBS Biopharma Conference 2023, Nov-08-2023 01:30 PM
Spanish fashion chain Tendam considers going public, according to its president RE
ALX Oncology Realigns Executive Leadership Team GL
ALX Oncology Realigns Executive Leadership Team AQ
ALX Oncology Holdings Inc. Appoints Jason Lettmann as Chief Executive Officer CI
ALX Oncology Holdings Inc. Appoints Dr. Jaume Pons Transitions to Chief Scientific Officer CI
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update GL
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights GL
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights AQ
Spain's Tendam sells its Russian stores to Belarusian company RE
Spain's Tendam hands Russian shops to Belarusian company RE
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma GL
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma AQ
ALX Oncology : 2023 Proxy Statement PU
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones GL
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones AQ
Meliá is studying the sale of some assets in the Caribbean to reduce its debt. RE
Transcript : ALX Oncology Holdings Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 10:30 AM
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023 GL
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference GL
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference AQ
Transcript : ALX Oncology Holdings Inc. - Special Call
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights GL
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights AQ
ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference GL
ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference AQ
ALX Oncology : Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights - Form 8-K PU
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights GL
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights GL
Spanish fashion retailer Tendam to keep free returns, online/in-store sales mix RE
ALX Oncology Announces Evorpacept Clinical Program Updates GL
ALX Oncology Announces Evorpacept Clinical Program Updates GL
ALX Oncology to Participate in the Jefferies 2022 Healthcare Conference GL
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights GL
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights AQ
ALX Oncology : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones - Form 8-K PU
ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones AQ
Transcript : ALX Oncology Holdings Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 10:30 AM
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022 GL
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022 GL
ALX Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference AQ
ALX Oncology : Corporate Presentation PU
123NextSee all

Companies (6)

UBIQUOSS INC. 118 M $
Logo Ubiquoss Inc.

Ubiquoss Inc. is a Korea-based company principally engaged in the manufacturing and distribution of network equipment. The Company’s products portfolio includes ethernet switches; fiber-to-the-home (FTTH) equipment including gigabit passive optical netw ...

HELIUS MEDICAL TECHNOLOGIES, INC. 5 M $
Logo Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancin ...

EOPTOLINK TECHNOLOGY INC., LTD. 8 502 M $
Logo Eoptolink Technology Inc., Ltd.

Eoptolink Technology Inc., Ltd. is a China-based company principally engaged in the research and development, manufacture and sale of optical modules. The Company's main products include point-to-point optical modules and passive optical network (PON) opt ...

LIGHTRON FIBER-OPTIC DEVICES INC. 74 M $
Logo Lightron Fiber-Optic Devices Inc.

Lightron Fiber-Optic Devices Inc, formerly LIGHTRON INC, is a Korea-based company engaged in the provision of optical module solutions for communications. The Company is engaged in the provision of passive optical network (PON) units, PON optical line ter ...

OE SOLUTIONS CO., LTD. 89 M $
Logo OE Solutions Co., Ltd.

OE Solutions Co., Ltd. is a Korea-based company mainly engaged in the manufacture and distribution of optical transceivers. The Company mainly provides optical transceiver solutions for broadband wireless and wireline markets, including wireless backhaul, ...

SOLID, INC. 255 M $
Logo SOLiD, Inc.

SOLiD, Inc. is a Korea-based company engaged in the manufacture of communication equipment such as wideband code division multiple access (WCDMA) repeaters and long term evolution (LTE) equipment. The Company mainly produces mobile communications equipmen ...


Insiders

Picture José Jaume Pons
José Jaume Pons

José Jaume Pons was a Director at Aena S.M.E.
SA.


Picture Jaume Pons
Jaume Pons

Jaume Pons is the founder of ALX Oncology Ltd.
(founded in 2015) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of ALX Oncology Holdings, Inc. (founded in 2015) where he holds the title of President, Director & Chief Scientific Officer.
Currently, Dr. Pons is the President & Chief Executive Officer of ALX Oncology, Inc. He is also a Director at Tallac Therapeutics, Inc., Alexo Therapeutics International, Sirpant Therapeutics, and LSV Capital Management LLC, where he serves as a Scientific Advisor.
Additionally, he is a Venture Partner at venBio Partners LLC since 2015.
In the past, Dr. Pons worked as the Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
He also held the position of Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed his graduate studies at the University of California, Berkeley.
He also holds undergraduate, graduate, and doctorate degrees from Universitat Autònoma de Barcelona.


Picture Jaume Carol Pañach
Jaume Carol Pañach

Jaume Carol Pañach holds the position of Global Manufacturing Director at Fluidra SA.


Picture Jaume Perdigó Pons
Jaume Perdigó Pons

Jaume Perdigó Pons is currently an Investment Director at Miura Partners SGEIC SA since 2022.
He is also a Board Member at Citrico Global SL and TIERRA - Ingeniería y Paisajismo SL.
In the past, he worked as an Investment Analyst at Suma Capital SGEIC SA from 2016 to 2017 and as an Investment Banking Analyst at Greenhill & Co. Spain Ltd.
from 2017 to 2019.
Mr. Perdigó Pons completed his undergraduate degree at ESADE Business School in 2016.




Picture Nico Pons
Nico Pons

Nico Pons currently works as a Commercial Manager-Short Sea Services at W.E.C.
Lines BV.






Picture John M. Pons
John M. Pons

John M.
Pons
is currently a Director at Rincon 222 LLC, RP Investments I LLC, Rincon 115 LLC, RP Investments II LLC, and Rincon SH2825 LLC.
He is also the Secretary, EVP & General Counsel at Cole Capital Partners LLC, Cole Realty Advisors LLC, Cole REIT Advisors LLC, Cole REIT Advisors II LLC, and Cole REIT Advisors III LLC.
In the past, Mr. Pons served as an Independent Director at Nexpoint Multifamily Capital Trust, Inc. He was also the Secretary at Cole Credit Property Trust, Inc. and Cole Credit Property Trust II, Inc. Additionally, he held the position of Secretary, Executive VP & General Counsel at Cole Real Estate Investments, Inc. and was an Associate General Counsel & Assistant Secretary at GE Capital Franchise Finance Corp.
He also served in the US Air Force as a Principal.
Mr. Pons completed his graduate degree at Central Michigan University and his undergraduate degree at Colorado State University.
He also obtained a graduate degree from the University of Denver in 1995.


Picture Jean-Luc Pons
Jean-Luc Pons

Jean-Luc Pons is currently a Director at APF France handicap since 2017.





Picture Francois Pons
Francois Pons

Francois Pons worked as a Director at Grant Thornton SA.













Picture Jean-Michel Pons
Jean-Michel Pons

Jean-Michel Pons is currently the Managing Director at Hima Cement Ltd.
and also holds the position of Executive Director at Bamburi Cement Co. Ltd.
since 2019.
Previously, he worked as the Director of Algeria & Serbia Business Development at Holcim Ltd.











Picture Jaume Ferre
Jaume Ferre

Jaume Ferre is currently the Chief Technology Officer at Wallbox NV since 2021.
He completed his undergraduate degree at the Polytechnic University of Catalonia.





Picture Jaume Germà
Jaume Germà

Jaume Germà currently works at Cooperativa 70 SCCL, as Member-Governing Council.





Picture Loïc Jaume
Loïc Jaume

Loïc Jaume currently works as a Director-Project & Implementation at Linedata Services Leasing & Credit.



















Picture Jaume Llobet
Jaume Llobet

Jaume Llobet is currently the Director of Finance & Administration at Parlem Telecom Companyia de Telecomunicacions SA. Previously, he worked as the Chief Financial Officer at Hanesbrands Spain SA.










Picture Jaume Solá
Jaume Solá

Jaume Solá is currently the Chief Investment Officer at Enerside Energy SA since 2021.
Prior to this, he worked as an Investment Analyst at Highgrowth Partners SGECR SA from 2007 to 2011.
Mr. Solá graduated from the University of Barcelona in 2006 and obtained an MBA from the University of Navarra in 2012.







Picture Jaume Curadó
Jaume Curadó

Mr. Jaume Curadó is a Private Banker & Wealth Adviser at Banco Alcalá SA. He has 23 years of experience in the private banking sector.
Mr. Curadó was previously employed as a Director-Private Banking by Banco de Sabadell SA (Private Banking), a Head of Private Banking by Caixa Penedés Gestió SGIIC SA, a Private Investment Advisor by Deutsche Bank AG (Pvt Banking Spain), and a Head of Risk & Controls by Caixa Catalunya Gestio SGIIC SA. He degree in Business Administration from University of Barcelona and European Financial Advisor (EFPA) certificate.




Picture Jaume Escala
Jaume Escala

Jaume Escala has worked as an Operations Director at Privat Asesoramiento.
Correduria.
De Seguros SL.








Picture Jordi Pons
Jordi Pons

Jordi Pons currently works at Eurona Wireless Telecom SA, as Chief Information Officer.



Picture Delphine Pons
Delphine Pons

Delphine Pons is currently the Distribution Director at Compagnie des Alpes SA and the Director at Compagnie du Mont-Blanc SA. Previously, she worked as the Group Director-Sales & Marketing at Leisure Parks Ltd.
Ms. Pons completed her undergraduate degree at ESSEC Business School.


Picture Dina Pons
Dina Pons

Dina Pons has worked as the Co-Head Asia Region & Impact Manager at Incofin Investment Management Comm.
VA since 2014.


Picture Dominique Pons
Dominique Pons

Dominique Pons formerly worked at Thales Avionics SA, as Vice Chairman-Technology Intelligence, III-V Lab GIE, as Chairman, Riber SA, as Independent Member-Supervisory Board from 2014 to 2015, and Diehl Aerospace GmbH, as Member-Supervisory Board.


Picture Bernard Pons
Bernard Pons

Bernard Pons is the founder of Pure Capital SA, where he holds the title of Chief Risk Officer starting in 2010.
He also worked as a Non-Executive Director at Leclanché SA from 2022 to 2023 and as a Portfolio Manager at Kredietrust Luxembourg SA.



Picture Josep Maria Rossell Pons
Josep Maria Rossell Pons

Josep Maria Rossell Pons is currently working as the Minister of Justice & Interior for the Government of Andorra.




No results for this search